V-9302 for Dummies
Whilst ADH-503 didn't target T cells immediately, our information recommend that it can augment anti-tumor T cell responses. We discovered that ADH-503 bolstered both of those CD8+ and CD4+ effector T cell responses by escalating their quantities, activation, and proliferative status. Interestingly, we observed elevated proximity of CD8+ T cells to